Literature DB >> 21840612

Assessment of tumor hypoxia and interstitial fluid pressure by gadomelitol-based dynamic contrast-enhanced magnetic resonance imaging.

Kristine Gulliksrud1, Tord Hompland, Kanthi Galappathi, Einar K Rofstad.   

Abstract

BACKGROUND AND
PURPOSE: Extensive hypoxia and high interstitial fluid pressure (IFP) in the primary tumor may cause resistance to radiation treatment and promote metastatic spread. The potential of gadomelitol-based dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in assessing the extent of hypoxia and the level of interstitial hypertension in tumors was investigated in this preclinical study.
MATERIALS AND METHODS: Twenty-three A-07 tumors were subjected to DCE-MRI and subsequent measurement of IFP and fraction of pimonidazole-positive hypoxic tissue (HF(Pim)). Parametric tumor images of K(trans), v(e), and V(b)(Tofts) (Tofts model) and of K(i) and V(b)(Patlak) (Patlak model) were produced by pharmacokinetic analyses of the DCE-MRI series.
RESULTS: There was no correlation between IFP and HF(Pim) in the tumors. K(trans) and K(i) decreased significantly with increasing HF(Pim), whereas V(b)(Tofts) and V(b)(Patlak) increased significantly with increasing IFP.
CONCLUSION: Information on both the extent of hypoxia and the level of interstitial hypertension in A-07 tumors can be derived from a single DCE-MRI series by using gadomelitol as contrast agent. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21840612     DOI: 10.1016/j.radonc.2011.06.036

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  2 in total

1.  BOLD-MRI of breast invasive ductal carcinoma: correlation of R2* value and the expression of HIF-1α.

Authors:  Min Liu; Xiaojuan Guo; Shuangkun Wang; Mulan Jin; Ying Wang; Jie Li; Jun Liu
Journal:  Eur Radiol       Date:  2013-07-09       Impact factor: 5.315

2.  Preclinical evaluation of Gd-DTPA and gadomelitol as contrast agents in DCE-MRI of cervical carcinoma interstitial fluid pressure.

Authors:  Tord Hompland; Christine Ellingsen; Einar K Rofstad
Journal:  BMC Cancer       Date:  2012-11-22       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.